Recursion Pharmaceuticals Statistics
NASDAQ: RXRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.45-0.27 (-9.93%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Recursion Pharmaceuticals by the numbers
Recursion Pharmaceuticals has a market capitalization of $1.53 billion based on 622.76M shares outstanding. With trailing EPS of $-0.86, Recursion Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 34.1% below its 50-day average and 28.9% below its 200-day average.
Average daily trading volume is 24.47M shares, or about $59.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RXRX valuation vs. peer median
| Metric | RXRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.53B | $1.52B | +1% |
| Avg. volume | 24.47M | 594.01K | +4019% |
Peer median across 8 companies: VIR, ALVO, WWB, MESO, IMCR, MAZE, LYCA, REPL.
Valuation
- Market cap
- $1.53B
- Price / sales (latest FY)
- 20.45
- EPS (TTM)
- $-0.86
- Shares outstanding
- 622.76M
Price and trading
- Previous close
- 2.72
- Open
- 2.63
- Day range
- 2.44 – 2.76
- 52-week range
- 2.44 – 5.24
- 52-week change
- -41.25%
- Beta
- —
- Volume
- 29.80M
- Average volume
- 24.47M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 1.53B
- Forward Pe
- -3.03
- Eps
- -0.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.24
- Week52 Low
- 2.44
- Avg Volume
- 24.47M
- Shares Outstanding
- 622.76M
- Ma50
- 3.72
- Ma200
- 3.44
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -53.24%
- Pct From52w Low
- 0.41%